CD34 and non-small cell lung carcinoma: Here, our experiments showed that MFI2-AS1 levels in circulating exosomes from metastatic NSCLC patients were higher than those from patients without metastases, and the CD34 positivity rate in the tissues of metastatic patients was also significantly higher than that of non-metastatic patients.